Biomerica (BMRA) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -7,423.00 |
| Nov 30, 2025 | 1,612.00 |
| Aug 31, 2025 | 16,586.00 |
| May 31, 2025 | -17,484.00 |
| Feb 28, 2025 | -3,079.00 |
| Nov 30, 2024 | -2,781.00 |
| Aug 31, 2024 | -3,048.00 |
| May 31, 2024 | -5,971.00 |
| Feb 29, 2024 | -13,445.00 |
| Nov 30, 2023 | -6,407.00 |
| Aug 31, 2023 | -3,014.00 |
| May 31, 2023 | -10,223.00 |
| Feb 28, 2023 | -12,634.00 |
| Nov 30, 2022 | -9,341.00 |
| Aug 31, 2022 | -11,298.00 |
| May 31, 2022 | -948.00 |
| Feb 28, 2022 | 1,890.00 |
| Nov 30, 2021 | -1,010.00 |
| Aug 31, 2021 | -11,875.00 |
| May 31, 2021 | -6,988.00 |
| Feb 28, 2021 | -4,877.00 |
| Nov 30, 2020 | -11,947.00 |
| Aug 31, 2020 | -15,992.00 |
| May 31, 2020 | -4,648.00 |
| Feb 29, 2020 | -6,419.00 |
| Nov 30, 2019 | -944.00 |
| Aug 31, 2019 | -2,139.00 |
| May 31, 2019 | -7,767.00 |
| Feb 28, 2019 | -5,565.00 |
| Nov 30, 2018 | -607.00 |
| Aug 31, 2018 | -1,904.00 |
| May 31, 2018 | -6,239.00 |
| Feb 28, 2018 | -2,086.00 |
| Nov 30, 2017 | -2,947.00 |
| Aug 31, 2017 | -3,152.00 |
| May 31, 2017 | -2,745.00 |
| Feb 28, 2017 | -3,228.00 |
| Nov 30, 2016 | -2,622.00 |
| Aug 31, 2016 | -1,226.00 |
| May 31, 2016 | -10,033.00 |
| Feb 29, 2016 | -1,535.00 |
| Nov 30, 2015 | 948.00 |